Emergent Biosolutions (0IGA) Share Forecast & Price Target
0IGA Analyst Ratings
0IGA Stock 12 Month Forecast
Average Price Target
$10.00▲(45.35% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Ram Selvaraju | H.C. Wainwright | $10 | buy | 45.35%Upside | Reiterated | 09/09/26 | ||
| Jessica Fye | J.P. Morgan | ― | sell | ― | Initiated | 08/21/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Ram Selvaraju | 09/09/26 | $10 | buy | 45.35%Upside | Reiterated | H.C. Wainwright | ||
| Jessica Fye | 08/21/26 | ― | sell | ― | Initiated | J.P. Morgan |
Best Analysts Covering Emergent Biosolutions
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.33% per trade.
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -18.50% per trade.
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 21.43% of your transactions generating a profit, with an average return of -21.06% per trade.
0IGA Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 1 | 2 | 2 |
| Buy | 3 | 2 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 2 | 3 | 3 | 3 |
In the current month, 0IGA has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. 0IGA average Analyst price target in the past 3 months is 10.00.
0IGA Financial Forecast
0IGA Earnings Forecast
Next quarter’s earnings estimate for 0IGA is -$0.39 with a range of -$0.41 to -$0.37. The previous quarter’s EPS was $0.60. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
0IGA Sales Forecast
Next quarter’s sales forecast for 0IGA is $123.22M with a range of $118.05M to $128.60M. The previous quarter’s sales results were $234.30M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.